Amryt Pharma plc (AMYT) Analyst Estimates Annual - Discounting Cash Flows
AMYT
Amryt Pharma plc
AMYT (NASDAQ)
Period Ending: 2025
12-31
2024
12-31
2023
12-31
Number of Analysts 1 2 4
Estimated Revenue
Low 595.1 427.7 304.3
Average 595.1 427.7 338.5
High 595.1 427.7 377.6
Estimated EBITDA
Low -271 -194.8 -172
Average -271 -194.8 -154.2
High -271 -194.8 -138.6
Estimated EBIT
Low -353 -253.7 -224
Average -353 -253.7 -200.8
High -353 -253.7 -180.5
Estimated Net Income
Low 17.78 16.79 -1.48
Average 17.78 16.79 -1.48
High 17.78 16.79 -1.48
Estimated SGA Expenses
Low 410.5 295 209.9
Average 410.5 295 233.5
High 410.5 295 260.5
Estimated EPS
Low 0.36 0.34 -0.03
Average 0.36 0.34 -0.03
High 0.36 0.34 -0.03
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program